Navigation Links
SEMBIOSYS ISSUED KEY U.S. PATENT FOR THE PRODUCTION OF APOLIPOPROTEINS IN PLANTS
Date:9/1/2010

CALGARY, Sept. 1 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS) today announced that the United States Patent and Trade Mark Office has granted the Company U.S. patent 7,786,352 entitled "Methods for the Production of Apolipoproteins in Transgenic Plants". The granted patent claims include the methods for the expression of apolipoprotein (Apo) in plants, including Apo AI(Milano), the introduction of related chimeric nucleic acid into plant cells and producing plant cells capable of growing into mature plants which produce seeds that express apolipoprotein. This patent is key to successfully commercializing plant made and seed expressed Apo AI(Milano).

The intent of the Company's global patent strategy is to own exclusive rights to transgenic production of biosimilar drugs and novel drug candidates like Apo AI(Milano) in select plant and plant-seed lines and to be able to make such drugs in a scalable and affordable manner. In doing so, the Company believes it is rapidly becoming a highly attractive partner to large pharma partners looking to enter these markets with a differentiated and patent protected manufacturing cost structure.

"The issuance of this patent and the continuing success of our Apo AI(Milano) development strengthens the program as we advance through the partnership process with interested parties. This newly granted patent significantly enhances the value of our development and commercialization program for Apo AI(Milano), our next-generation cardiovascular drug candidate with blockbuster potential," said James Szarko, President and CEO of SemBioSys. "Apo AI(Milano) has the potential to address large unmet medical needs as an acute treatment for atherosclerosis or arterial blockage caused by plaque build-up on arterial walls, which leads to stroke and heart attacks. Our plant-seed based expression system for the production of Apo, biosimilar drugs and potentially other novel pharmaceutical drug candidates is a truly disr
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
2. SemBioSys begins phase I/II trial of insulin produced in plant seeds
3. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
4. SemBioSys announces senior management changes
5. SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin
6. SemBioSys provides update on insulin program
7. SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC
8. SemBioSys plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models
9. Data for SemBioSys insulin to be presented at the American Diabetes Associations 69th Scientific Sessions
10. SemBioSys provides an update on Botaneco
11. SemBioSys announces third quarter 2009 financial and operational results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Seattle, WA (PRWEB) July 29, 2014 ... central IRB services, has been awarded accreditation by ... (IASSC) for its Lean Six Sigma Deployment ... eliminate waste and improve performance. , Quorum’s Lean ... granted the Accredited Deployment Program designation. The designation ...
(Date:7/29/2014)... CA (PRWEB) July 29, 2014 ... Pipette.com’s centrifugation product selection. Eppendorf 5427 R is geared ... and DNA – it is targeted towards work requiring ... Centrifuge 5427 R as it compliments their extensive 16, ... Eppendorf line of microcentrifuge tubes, PCR tubes, PCR strip ...
(Date:7/29/2014)... EXpressLO LLC, expert provider of focused ... solutions, has been granted patent number 8,789,826 by the ... incorporating a unique specimen carrier support grid design described ... company patent for EXpressLO LLC awarded to founder and ... complementary patents extend EXpressLO’s portfolio of intellectual property. The ...
(Date:7/28/2014)... July 28, 2014 The Workgroup for ... on the use of health IT to create efficiencies ... Plan Identifier (HPID) Workgroup has developed an issue ... Plan and Payer?” The HPID Workgroup, a part of ... the Centers for Medicare and Medicaid Services (CMS) to ...
Breaking Biology Technology:Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3International Pipette Distributor, Pipette.com Announces the Addition of the Eppendorf Centrifuge 5427 R to Their Product Portfolio 2EXpressLO LLC Granted Second U.S. Patent for Innovative Specimen Preparation Methods 2WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?” 2
... VANCOUVER, Sept. 13 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. ... today that it received a,favourable decision from ... an attempt by Johnson & Johnson,s subsidiary, ... Zealand Patent 523799, which,pertains to compositions comprising ...
... ROCKVILLE, Md., Sept. 12 BioReliance Corporation, ... and,pharmaceutical industries, has contracted with Gentronix to ... a major part of BioReliance,s portfolio of,genotoxicity ... Ames,II assays, allows pharmaceutical companies to test ...
... 2007 Medical Products Industry Leader, DEERFIELD, Ill., Sept. ... today that it has been named 2007,Medical Products Industry ... and the Dow Jones Sustainability North America Index,(DJSI North ... has been listed in the DJSI and the sixth ...
Cached Biology Technology:Angiotech receives favourable patent decision from New Zealand's Intellectual Property Office 2Angiotech receives favourable patent decision from New Zealand's Intellectual Property Office 3Angiotech receives favourable patent decision from New Zealand's Intellectual Property Office 4BioReliance Launches Next-Generation Genotoxicity Screening Service 2Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year 2
(Date:7/29/2014)... from scientists at the University of Kent has shown ... are regulated a breakthrough that could have a ... from Kent,s School of Biosciences uncovered the mechanism whereby ... known as actin filaments are ,fine-tuned, to ... filaments appear to completely stable, providing a framework for ...
(Date:7/29/2014)... a rare disease it affects 1 in 100,000 people ... esophageal wall. While its cause remains unknown, a new study ... the University of Bonn in Germany and other European institutions ... origin. The study, published on 6 July in Nature ... disease. , When we swallow, a sphincter in the lower ...
(Date:7/28/2014)... the South Pole in 1911, but new research shows ... , Using data from 16 ice cores collected from ... South Pole, a group led by Joe McConnell of ... the most accurate and precise reconstruction to date of ... described in an article published today in the online ...
Breaking Biology News(10 mins):Mysterious esophagus disease is autoimmune after all 2Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3
... the arteries weren't bad enough, a research team from the ... Newark has now confirmed that even our veins stiffen as ... are nice and elastic--like rubber bands," William Farquhar, a cardiovascular ... you grow older, we've found that your veins become more ...
... during periods of stress may increase the growth rate of ... that an increase in norepinephrine, a stress hormone, can stimulate ... down of the tissue around the tumor cells and allow ... there, they can travel to another location in the body ...
... first time, coaxed umbilical cord blood stem cells to differentiate into ... into a type of lung cell called type II alveolar cells. ... allows the air sacs in the lungs to remain open, allowing ... are also responsible for helping to repair the airway after injury. ...
Cached Biology News:Researchers show that veins stiffen as we age 2Researchers show that veins stiffen as we age 3Researchers show that veins stiffen as we age 4Stress hormones may play new role in speeding up cancer growth 2Stress hormones may play new role in speeding up cancer growth 3U of MN researchers turn cord blood into lung cells 2
... The SilverQuest Silver Staining Kit is ... staining sensitivity with minimal protein modification ... mass spectrometry problems associated with traditional ... SilverQuest kit because the reagents used ...
...
... Insect Medium is formuatled for the ... Sf9 and Sf21 cells. Grace's Insect ... because it does not contain lactalbumin ... with transfection. Grace's Insect Medium, Supplemented ...
Schneider's Drosophila Medium is formulated for the expression of heterologous proteins in Drosophila S2 cells....
Biology Products: